Skip to main content
. 2019 Jun 4;10:2040622319853719. doi: 10.1177/2040622319853719

Table 2.

Adjusted hazard ratios of all-cause mortality associated with antidepressants use during the follow-up period in all recruited patients.

Variables 28–167 cDDD
⩾168 cDDD
HR 95% CI p value HR 95% CI p value
Main modela 0.98 0.93 1.03 0.3307 0.65 0.62 0.69 <0.0001
Additional covariatesb
 Main model + Severity of depression 0.97 0.92 1.02 0.2917 0.65 0.62 0.68 <0.0001
 Main model + ADs use within 1 year before Index date 0.93 0.88 0.98 0.0074 0.61 0.58 0.64 <0.0001
 Main model + CCI 0.97 0.92 1.02 0.2287 0.66 0.62 0.69 <0.0001
 Main model + Coronary artery disease 0.97 0.92 1.02 0.2847 0.65 0.62 0.68 <0.0001
 Main model + Heart failure 0.98 0.93 1.03 0.3990 0.66 0.63 0.69 <0.0001
 Main model + End stage renal disease 0.98 0.93 1.03 0.3532 0.65 0.62 0.69 <0.0001
 Main model + Chronic obstructive pulmonary disease 0.98 0.93 1.03 0.3320 0.66 0.63 0.69 <0.0001
 Main model + Malignancy 0.97 0.92 1.02 0.2156 0.65 0.62 0.68 <0.0001
 Main model + Diabetes 0.97 0.92 1.02 0.2515 0.65 0.62 0.69 <0.0001
 Main model + Hypertension 0.98 0.93 1.03 0.3284 0.65 0.62 0.68 <0.0001
 Main model + Donepezil 0.98 0.93 1.03 0.3856 0.66 0.63 0.69 <0.0001
 Main model + Rivastigmine 0.98 0.93 1.03 0.3852 0.66 0.63 0.69 <0.0001
 Main model + Galantamine 0.98 0.93 1.03 0.3499 0.65 0.62 0.69 <0.0001
 Main model + Memantine 0.98 0.93 1.03 0.3467 0.66 0.63 0.69 <0.0001
Subgroup effects
 Gender
  Male 0.96 0.90 1.03 0.2914 0.64 0.60 0.68 <0.0001
  Female 0.99 0.92 1.07 0.8169 0.67 0.62 0.72 <0.0001
 Age (year)
  60–80 0.99 0.92 1.06 0.7021 0.63 0.59 0.67 <0.0001
  >80 0.96 0.89 1.03 0.2580 0.68 0.63 0.73 <0.0001
 Severity of depression
  Major depression 0.92 0.83 1.03 0.1557 0.56 0.51 0.62 <0.0001
  Minor depression 0.98 0.92 1.04 0.4046 0.68 0.64 0.72 <0.0001
 ADs use within 1 year before Index date
  Yes 0.94 0.86 1.03 0.1835 0.60 0.55 0.66 <0.0001
  No 0.92 0.86 0.98 0.0138 0.61 0.57 0.66 <0.0001
a

Main model was adjusted for gender, age, urbanization, income, and year of index date.

b

The models were adjusted for covariates in the main model as well as each additional listed covariate.

cDDD: cumulative defined daily dosage; HR: hazard ratio; CI: confidence interval; ADs: antidepressants; CCI: Charlson comorbidity index.